227
Views
10
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 72-79 | Received 15 Aug 2021, Accepted 22 Jan 2022, Published online: 01 Feb 2022

References

  • Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50(7):573–583.
  • Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22(10 suppl B):6B–14B.
  • Singh M, Berger PB, Ting HH, et al. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo clinic experience). Am J Cardiol. 2001;88(10):1091–1096.
  • Mewton N, Roubille F, Bresson D, et al. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021;144(11):859–869.
  • Cole J, Htun N, Lew R, et al. Colchicine to prevent periprocedural myocardial injury in percutaneous coronary intervention: the COPE-PCI pilot trial. Circ Cardiovasc Interv. 2021;14(5):e009992.
  • Sisakian HS, Mkhitaryan AG, Sahakyan VG, et al. Morphological and immunohystochemical characteristics of aspirated thrombi in patients with ST-Elevation myocardial infarction. Ter Arkh. 2019;91(9):21–25.
  • Ince LM, Weber J, Scheiermann C. Control of leukocyte trafficking by stress-associated hormones. Front Immunol. 2018;9:3143.
  • Duman H, Çinier G, Bakırcı EM, et al. Relationship between C-Reactive protein to albumin ratio and thrombus burden in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2019;25:107602961882441.
  • Hamur H, Duman H, Bakirci EM, et al. Bilirubin levels and thrombus burden in patients with ST-segment elevation myocardial infarction. Angiology. 2016;67(6):565–570.
  • Arısoy A, Altunkaş F, Karaman K, et al. Association of the monocyte to HDL cholesterol ratio with thrombus burden in patients with ST-Segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2017;23(8):992–997.
  • Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. WJG. 2017;23(34):6261–6272.
  • Diao P, Wu Y, Li J, et al. Preoperative systemic immune inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med. 2018;16(1):365.
  • Jomrich G, Gruber ES, Winkler D, et al. Systemic Immune- Inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020; 24(3):610–618.
  • Huang J, Zhang Q, Wang R, et al. Systemic Immune-Inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Monit. 2019;25:9690–9701.
  • Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230.
  • Erdoğan M, Erdöl MA, Öztürk S, et al. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14(16):1553–1561.
  • Agus HZ, Kahraman S, Arslan C, et al. Systemic immune-inflammation index predicts mortality in infective endocarditis. J Saudi Heart Assoc. 2020;32(1):58–64.
  • Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21):2550–2554.
  • Niccoli G, Spaziani C, Marino M, et al. Effect of chronic aspirin therapy on angiographic thrombotic burden in patients admitted for a first ST-elevation myocardial infarction. Am J Cardiol. 2010;105(5):587–591.
  • Tanboga IH, Topcu S, Aksakal E, et al. Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2014;20(7):716–722.
  • Yıldırım A, Kücükosmanoglu M, Koyunsever NY, et al. Association between serum SCUBE1 levels and thrombus burden in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2021;76(7):777–784.
  • Ateş AH, Arslan U, Aksakal A, et al. Plasma chemerin levels are increased in ST elevation myocardial infarction patients with high thrombus burden. Cardiol Res Pract. 2018;2018:1–5.
  • Gurbuz AS, Ozturk S, Efe SC, et al. Heparanase is a predictive marker for high thrombus burden in patients with ST-segment elevation myocardial infarction. Biomarkers. 2019;24(6):600–606.
  • Thålin C, Hisada Y, Lundström S, et al. Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis. Arterioscler Thromb Vasc Biol. 2019;39(9):1724–1738.
  • Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost. 2019;45(1):86–93.
  • Döring Y, Libby P, Soehnlein O. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res. 2020;126(9):1228–1241.
  • Budzianowski J, Pieszko K, Burchardt P, et al. The role of hematological indices in patients with acute coronary syndrome. Dis Markers. 2017;2017:3041565.
  • Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–150.
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131.
  • Ridker PM, Everett BM, Pradhan A, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752–762.
  • Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–2505.
  • Hong X, Cui B, Wang M, et al. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236(4):297–304.
  • Yang R, Chang Q, Meng X, et al. Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295–3302.
  • Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91–96.
  • Geng Y, Shao Y, Zhu D, et al. Systemic Immune-Inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep. 2016;6:39482.
  • Gao Y, Guo W, Cai S, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma. J Cancer. 2019;10(14):3188–3196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.